Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 64Cu-porphyrin chelation site within the porphysome bilayer is a specialized chemical environment created by the self-assembly of porphyrin-lipid conjugates into nanovesicles (Zheng et al., 2011, Nature Materials). These porphysomes are unique because the porphyrin building blocks themselves act as the chelating agents for metal ions like Copper-64, eliminating the need for additional external chelating molecules (Liu et al., 2011, Angewandte Chemie). This site allows for the stable incorporation of radiolabels, making the nanoparticles highly effective for positron emission tomography (PET) imaging in oncology. In addition to its role in imaging, the dense packing of porphyrins within the bilayer facilitates efficient photothermal conversion, where laser energy is transformed into localized heat to kill cancer cells (Ng et al., 2013, ACS Nano). The porphysome platform exploits the enhanced permeability and retention (EPR) effect to accumulate preferentially in tumor tissues. Because the chelation occurs within the bilayer, the radiolabel is protected and the structural integrity of the nanoparticle is maintained during circulation. This technology represents a significant advancement in theranostics, combining diagnostic imaging and therapeutic intervention into a single nanostructure.
Intrinsic chelation of Copper-64 radioisotopes for PET imaging and high-efficiency light-to-heat conversion for photothermal therapy.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Copper-64 porphyrin chelation site within porphysome bilayer (64Cu-porphysome).